[go: up one dir, main page]

HK1139399A1 - - Google Patents

Info

Publication number
HK1139399A1
HK1139399A1 HK10106008.5A HK10106008A HK1139399A1 HK 1139399 A1 HK1139399 A1 HK 1139399A1 HK 10106008 A HK10106008 A HK 10106008A HK 1139399 A1 HK1139399 A1 HK 1139399A1
Authority
HK
Hong Kong
Application number
HK10106008.5A
Inventor
Sean Dalziel
Leticia M Preza
Miroslav Rapta
Pierre-Jean Colson
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39620376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1139399(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of HK1139399A1 publication Critical patent/HK1139399A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK10106008.5A 2007-02-28 2010-06-15 HK1139399A1 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90409007P 2007-02-28 2007-02-28
PCT/US2008/002583 WO2008106159A1 (en) 2007-02-28 2008-02-27 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Publications (1)

Publication Number Publication Date
HK1139399A1 true HK1139399A1 (xx) 2010-09-17

Family

ID=39620376

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10106008.5A HK1139399A1 (xx) 2007-02-28 2010-06-15

Country Status (27)

Country Link
US (7) US7943772B2 (xx)
EP (1) EP2132204B1 (xx)
JP (2) JP5512289B2 (xx)
KR (1) KR101480530B1 (xx)
CN (1) CN101616916B (xx)
AR (2) AR065554A1 (xx)
AU (1) AU2008219615B2 (xx)
BR (1) BRPI0807974B8 (xx)
CA (1) CA2678073C (xx)
CL (1) CL2008000573A1 (xx)
CO (1) CO6220856A2 (xx)
CY (1) CY1115077T1 (xx)
DK (1) DK2132204T3 (xx)
ES (1) ES2402031T3 (xx)
HK (1) HK1139399A1 (xx)
HR (1) HRP20130193T1 (xx)
IL (1) IL200131A (xx)
MX (1) MX2009009141A (xx)
MY (1) MY148318A (xx)
NZ (1) NZ578871A (xx)
PL (1) PL2132204T3 (xx)
PT (1) PT2132204E (xx)
RU (1) RU2458061C2 (xx)
SI (1) SI2132204T1 (xx)
TW (1) TWI409067B (xx)
WO (1) WO2008106159A1 (xx)
ZA (1) ZA200905832B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY145633A (en) * 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI409067B (zh) 2007-02-28 2013-09-21 Theravance Inc 8-氮雜雙環〔3.2.1〕辛烷化合物之結晶型
TWI415850B (zh) * 2007-07-20 2013-11-21 Theravance Inc 製備mu類鴉片受體拮抗劑之中間物的方法
US7902221B2 (en) * 2007-08-27 2011-03-08 Theravance, Inc. Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
ATE502939T1 (de) * 2007-08-27 2011-04-15 Theravance Inc Disubstituierte alkyl-8-azabicycloä3.2.1üoktan- verbindungen als mu-opioid-rezeptorantagonisten
TWI423801B (zh) 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物
WO2009029253A1 (en) * 2007-08-27 2009-03-05 Theravance, Inc. Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TW201118084A (en) * 2009-09-18 2011-06-01 Adolor Corp The use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders
DK3277278T3 (da) 2015-04-02 2020-04-06 Theravance Biopharma R&D Ip Llc Kombinationsdoseringsform af en my-opioid receptorantagonist og et opioid

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US6900228B1 (en) * 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB9912410D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US6469030B2 (en) * 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
US6467084B1 (en) * 1999-12-16 2002-10-15 Emware, Inc. Systems and methods for reprogramming an embedded device with program code using relocatable program code
IL151550A0 (en) 2000-03-03 2003-04-10 Ortho Mcneil Pharm Inc 3-(diarylmethylene)-8-azabicyclo [3.2.1] octane derivatives
US20020025948A1 (en) * 2000-06-23 2002-02-28 Banks Bernard Joseph 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
UA75714C2 (en) * 2001-10-22 2006-05-15 Pfizer Prod Inc 3-azabicyclo [3.1.0] hexane derivatives as opioid receptor antagonists and pharmaceutical composition based thereon
US7381721B2 (en) * 2003-03-17 2008-06-03 Adolor Corporation Substituted piperidine compounds
US7056930B2 (en) * 2003-04-14 2006-06-06 Pfizer Inc. 2-Azabicyclo[3.3.1]nonane derivatives
US20040204453A1 (en) * 2003-04-14 2004-10-14 Pfizer Inc 4-Phenyl-piperidine compounds and their use as modulators of opioid receptors
CA2522323C (en) * 2003-04-14 2009-09-15 Pfizer Products Inc. 3-azabicyclo[3.2.1]octane derivatives as opioid receptor ligands
EP1615920A1 (en) 2003-04-15 2006-01-18 Pfizer Products Inc. 3-benzhydrylidene-8-aza-bicyclo [3.2.1] octane derivatives with opioid receptor activity
US6992090B2 (en) * 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
US7435822B2 (en) 2004-02-03 2008-10-14 Janssen Pharmaceutica N.V. 3-(diheteroarylmethylene)-8-azabicyclo[3.2.1]octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives
US7087749B2 (en) * 2004-03-11 2006-08-08 Adolor Corporation Substituted piperidine compounds and methods of their use
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
US20100284960A1 (en) 2006-11-07 2010-11-11 Nektar Therapeutics Al, Corporation Dosage Forms and Co-Administration of Opioid Agonist and Opioid Antagonist
TWI409067B (zh) * 2007-02-28 2013-09-21 Theravance Inc 8-氮雜雙環〔3.2.1〕辛烷化合物之結晶型

Also Published As

Publication number Publication date
AU2008219615B2 (en) 2013-05-09
CY1115077T1 (el) 2016-12-14
CO6220856A2 (es) 2010-11-19
EP2132204B1 (en) 2013-01-23
EP2132204A1 (en) 2009-12-16
US8536335B2 (en) 2013-09-17
US20180200246A1 (en) 2018-07-19
MY148318A (en) 2013-03-29
ZA200905832B (en) 2010-05-26
TW200845984A (en) 2008-12-01
MX2009009141A (es) 2009-09-03
BRPI0807974A2 (pt) 2014-09-16
HRP20130193T1 (hr) 2013-03-31
JP5512289B2 (ja) 2014-06-04
IL200131A (en) 2013-03-24
US10426766B2 (en) 2019-10-01
SI2132204T1 (sl) 2013-05-31
BRPI0807974B1 (pt) 2020-11-24
ES2402031T3 (es) 2013-04-26
US20160287572A1 (en) 2016-10-06
CN101616916B (zh) 2011-10-12
TWI409067B (zh) 2013-09-21
KR101480530B1 (ko) 2015-01-08
IL200131A0 (en) 2010-04-15
CN101616916A (zh) 2009-12-30
US9949963B2 (en) 2018-04-24
PL2132204T3 (pl) 2013-06-28
CA2678073A1 (en) 2008-09-04
AR109224A2 (es) 2018-11-07
AU2008219615A1 (en) 2008-09-04
BRPI0807974B8 (pt) 2021-05-25
JP2013151564A (ja) 2013-08-08
CL2008000573A1 (es) 2008-05-16
US8816091B2 (en) 2014-08-26
US7943772B2 (en) 2011-05-17
US20130072515A1 (en) 2013-03-21
US20080207676A1 (en) 2008-08-28
WO2008106159A1 (en) 2008-09-04
US20150073014A1 (en) 2015-03-12
DK2132204T3 (da) 2013-04-29
US8247555B2 (en) 2012-08-21
NZ578871A (en) 2012-01-12
AR065554A1 (es) 2009-06-17
RU2009135834A (ru) 2011-04-10
US9290491B2 (en) 2016-03-22
RU2458061C2 (ru) 2012-08-10
CA2678073C (en) 2016-01-05
JP2010520198A (ja) 2010-06-10
US20140080856A1 (en) 2014-03-20
PT2132204E (pt) 2013-03-25
US20110184008A1 (en) 2011-07-28
KR20090115767A (ko) 2009-11-05

Similar Documents

Publication Publication Date Title
BRMU8803459U2 (xx)
CN300833623S (zh) 杯垫(bd29)
CN300731622S (zh) 穿线盒
CN300903454S (zh) 茶叶包装盒(4011-25g)
CN300889742S (zh) Ic卡(071215)
CN300872888S (zh) 杯垫(071537)
CN300728360S (zh) 手电(zl-910)
CN300728349S (zh) 化粪池(卧式)
CN300728287S (zh) 型材(单推拉窗边封)
CN300728253S (zh) 分体挂壁式空调器(yz)
CN300730357S (zh) 瓶贴(米婆婆泰糯)
CN300728194S (zh) 怀炉(2)
CN300728129S (zh) 钓鱼用导环(xl)
CN300727674S (zh) 电话机(3617)
CN300727526S (zh) 断路器(tgm88-125)
CN300730247S (zh) 胶纸座(pod-06)
CN300727333S (zh) 摩托车仪表罩
CN300869110S (zh) 纺织面料(07-2995)
CN300863626S (zh) 餐桌(w-938)
CN300727144S (zh) 包装袋(安力嘉·女士配方奶粉400克)
CN300726334S (zh) 椅(1161h)
CN300730066S (zh) 显示器(ul-1929w)
CN300857468S (zh) 厅柜(mz02-mo02-01a)
CN300839678S (zh) 展品柜(蛙系列展品柜-4)
CN300731938S (zh) 包装瓶(白色)